抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf

抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf

ID:54924718

大小:544.94 KB

页数:9页

时间:2020-05-04

抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf_第1页
抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf_第2页
抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf_第3页
抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf_第4页
抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf_第5页
资源描述:

《抗病毒治疗对慢乙肝相关致癌因素的干预研究-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库

1、现代生物医学进展www.shengwuyixue.comProgressinModernBiome~cineVoL14NOg.0JUL2014·3909·doi:10.132418.cnki.pmb.2014.20.029TheStudyofInterventionOfAntiviralTherapytoChronicHepatitisB.RelatedCarcinogensCHENFe,WANGZhe-linge,GAOR砸,L1UZhong-jingeflQingdaoUniversRy;Qing

2、dao,Shandong,266021,China;2QingdaoInfectiousDiseasesHospital,Qingdao,Shandong,266033,C盈血】a】ABSTRACTObjective:Toinvestigatetheinterventionofantiviralther~yontheriskfactorsofchronichepatitisB-relatedhepatoc-ellularcarcinoma.Methods:249hospitalizedcasesofh

3、epatocellularcarcinomainQingdaoInfectiousDiseasesHospitalfromFebruary2010toJune2012wereretrospectivelyanalyzed.Therelevantdatarecordedonthequestionnairepreparedbytheunifiedwasusedtocomparethedistributionofvariousfactorsbetweenantiviraltreatmentgroupandn

4、o—antiviraltreatmentgroup.Results:ThediferencesoftimeofHBVinfectionandthatofcirrhosisbeforediagnosedwithHCC,andHBVDNAlevelbetweenantiviraltreatmentgroupandno-antiviraltreatmentgroupwerestatisticallysignificant,P<0.05;HBVinfectionpatterns,AFP,CEAhadnosig

5、nificantdiferencesbetweenthetwogroups.Diferencesofrelatedindicatorsofliverfunctionwerestatisticallysignificant.Conclusions:AntiviralthempycouldsignificantlyreducethepercentageofthecarcinogenicfactorsassociatedwithchronichepatitisBinpatients,anditcanefec

6、tivelyinhibitthereplicationofHBVDNA,whichmaybereducetheincidenceofHBV-relatedHCC.Keywords:Hepatocellularcarcinoma;ChronichepatitisB:Riskfactors;AntiviraltherapyChineseLibraryClassifieation(CLC):R512.6,R735.7Documentcode:AArticleID:1673-6273(2014)20-3909

7、·-05metabolicandotherreasonscirhosis,thecancerofotherpartsandIntroductionmetastaticlivercanceralsowereremoved.Thesubjectsaredivid-ChronichepatitisBvirus(HBV)infectionisthemainreasonedintoantiviraltreatmentgroupandno-antiviraltreatmentgroupofhepatocellul

8、arcarcinoma(HCC)inChina.ThemajorityofHCCbasedthatiftheytooktheoralnucleosideantiviraldrugs.isevolvedfromcirrhosisafterHBVinfectionB21.andtherelevant1.2ContentsoftheobservationinformationshowsthathighHBVDNAlevelistheabsoluteriskAl

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。